Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.
Ananda
Sumitra
S
Field
Kathryn M
KM
Kosmider
Suzanne
S
Compston
Daniel
D
Desai
Jayesh
J
Lim
Lionel C
LC
Barnett
Frances S
FS
Jones
Ian T
IT
Skinner
Iain
I
Gibbs
Peter
P
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology; D015897:Comorbidity; D005260:Female; D006306:Health Surveys; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*
D000970:Antineoplastic Agents